DOCU
DOCU
Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.
Insider Buys
0
$0
Insider Sales
0
$0
Total Volume
$0
49 transactions
Net Activity
+$0
Net buying
Sentiment Rating
Neutral / BalancedCEO Conviction Index
No Recent Signal
Key Drivers
- •Balanced trading volume with net neutral buying and selling activity.
Score Methodology
The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:
- +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
- +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
- +15CEO Buying: CEO committing own capital shows high conviction.
- +10CFO Buying: CFO purchasing shares shows financial alignment.
DOCU has an insider buy conviction of 50%, compared to the Unknown sector buy average of 50%. DOCU ranks #133 in insider activity out of 293 tracked companies in its industry.
Multiple Insiders
S - Sale Insiders
$0 total
Over the last 90 days, corporate insiders at DOCU (DOCU) engaged in a total of 49 transactions reported via SEC Form 4 filings. Among these, 0 were open-market purchases and 0 were sales. The total volume of insider trading reached $0.
The net insider activity for DOCU shows a net buying bias of $0. This activity represents a 50% buy ratio, suggesting that insiders are currently neutral on the company's near-term outlook relative to recent history.
The most notable individual transaction was a Sale by Multiple Insiders (S - Sale Insiders), who traded 75.9K shares valued at $0 on Sep 17, 2026.
Quick Actions
Related News & Analyst Reports
Read original insights and educational research covering DOCU and the Unknown sector.
Unusual Insider Buying Patterns: Spotting the Anomalies
Beyond simple purchase screens, unusual insider buying patterns, accelerating purchase velocity, off-hours filings, purchases during active 10b5-1 plans, can reveal extraordinary conviction. This guide documents nine pattern types and their historical signal accuracy.
Venture-Backed Biotech IPOs: Inside the 2026 Buying Spree
2026 saw a resurgence of venture-backed biotech IPOs, accompanied by unusually high post-lockup insider buying. This report documents the specific Form 4 cluster events, purchase sizes, and 90-day price performance across a dozen recent biotech offerings.
The Danger of Following 'Dump' Filings: Sells That Mean Nothing
Form 4 sell transactions flood the tape daily, RSU vesting, option exercises, 10b5-1 plan executions. This guide documents the seven categories of insider sales that carry zero predictive value and how to filter them from your screener.
Why Block Purchases by Officers Outperform Smaller Regular Transactions
Large open-market purchases, $500K or more, by C-suite officers carry disproportionate forward-return predictive power compared to smaller, routine insider buys. This backtested study defines the block purchase threshold and documents the performance premium.
How to Detect Potential Accounting Red Flags via C-Suite Disposals
Aggressive insider selling just before a restatement or SEC inquiry is a recurrent pattern. This report documents the Form 4 signals that preceded major accounting scandals and teaches you to recognize the early warning signs.
What a Sudden Cessation of Insider Selling Tells Us About a Company
When persistent insider selling abruptly stops, it often signals that executives believe the stock is undervalued or that a material event is approaching. This report documents the forward-return profile of sudden sell-cessation events across 10 years of Form 4 data.
FAQs About DOCU Insider Trading
Answers to common questions regarding corporate filings and executive sentiment for DOCU.